Propharma Group LLC
Raleigh, NC Doing business as Acadeus
- UEI
- N6C8UMMHCB15
- CAGE
- 57X20
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- NAICS codes registered in SAM.gov
-
- 541611 Administrative Management and General Management Consulting Services Primary
- 339113 Surgical Appliance and Supplies Manufacturing
- 513210 Software Publishers
- 541330 Engineering Services
- 541618 Other Management Consulting Services
- 541690 Other Scientific and Technical Consulting Services
- 541990 All Other Professional, Scientific, and Technical Services
- SAM.gov registration date
- Physical address
- 107 W Hargett St Fl 5, Raleigh, NC 27601, USA
- Website
- propharmagroup.com
- Founded
- 2001
- Employees
- 1K-5K
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Director of quality assurance for CCE | NIH Clinical Center | $415,594 | |
| Procurement of director of quality assurance services for CCE | NIH Clinical Center | $218,962 | |
| Additional funding for BPA extension | NIH Clinical Center | $300,000 | |
| Propharma group, LLC:1334339 [23-013966] quality assurance activities | NIH Clinical Center | $1,061,913 | |
| Propharma group, LLC:1334339 [24-005743 ] supplemental clinical research and regulatory support staffing | NIH Clinical Center | $0 |
About Propharma Group LLC
Propharma Group LLC, doing business as Acadeus, is a for-profit Subchapter S Corporation and Research Consulting Organization (RCO) specializing in expert consulting services for federal healthcare and medical research agencies. Registered in SAM.gov since October 2008, the company provides comprehensive consulting solutions primarily focused on regulatory sciences, clinical research, quality assurance, pharmacovigilance, and operational support. Their core competencies include expert consulting services designed to improve patient health and safety throughout product lifecycles, with a particular emphasis on supporting federal agencies in complex research and regulatory environments.
The company has performed extensive consulting work primarily for the National Institutes of Health (NIH) Clinical Center through multiple Blanket Purchase Agreement (BPA) call contracts under the Multiple Award Schedule (MAS). These contracts have encompassed a wide range of services, including quality unit reorganization, investigational drug management, operational planning, regulatory compliance, and staffing support for various research and clinical programs. Notably, Propharma Group has provided specialized services such as pharmacy compliance consulting, aseptic processing facility assessments, and development of operational procedures for investigational drug control units. The contracts have ranged in value from approximately $50,000 to $1.7 million, consistently supporting the NIH's research and compliance initiatives. Additionally, they have performed FDA audit consultation services for the Department of Veterans Affairs, demonstrating their versatility across federal agencies.
Regarding federal grant awards, Propharma Group LLC has participated as a sub-recipient on research grants, with multiple sub-awards documented in May and March of 2022. These sub-awards were associated with research activities, though specific details about the precise nature of the research were not extensively elaborated in the available documentation. The sub-awards were primarily connected to The Drug Delivery Company, LLC as the prime grantee, indicating Propharma Group's role in supporting broader research initiatives through collaborative grant mechanisms.
Propharma Group LLC holds a significant Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Food and Drug Administration (FDA), valued at $25 million, which runs through March 6, 2027. This contract focuses on the review of Laboratory-Developed Tests (LDTs) and In Vitro Diagnostics (IVDs). Under this IDV, they have already been awarded a $7.736 million delivery order running from March 2022 through September 2024, supporting the FDA's critical work in evaluating and regulating medical diagnostic technologies. This IDV represents a major strategic contract that positions Propharma Group as a key provider of specialized scientific and regulatory review services to a prominent federal agency.
Contract vehicles
Quick answers
What is Propharma Group LLC's UEI?
Propharma Group LLC's Unique Entity ID (UEI) in SAM.gov is N6C8UMMHCB15.
What is Propharma Group LLC's CAGE code?
Propharma Group LLC's CAGE code is 57X20.
What is Propharma Group LLC's primary NAICS code?
Propharma Group LLC's primary NAICS code is 541611 (Administrative Management and General Management Consulting Services).
Where is Propharma Group LLC located?
Propharma Group LLC's physical address in SAM.gov is 107 W Hargett St Fl 5, Raleigh, NC 27601, USA.
Is Propharma Group LLC registered in SAM.gov?
Yes. Propharma Group LLC's SAM.gov registration is active through March 5, 2027.
Which contract vehicles does Propharma Group LLC hold?
Propharma Group LLC holds a place on 2 federal contract vehicles, including MAS and PSS.
What is Propharma Group LLC's most recent federal award?
Propharma Group LLC's most recent federal contract award is Director of quality assurance for CCE (75N90026P00081), from NIH Clinical Center, on January 31, 2026.
On GovTribe
See Propharma Group LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors